UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks

Science, Innovation and Technology Committee Closed Inquiry
Opened: 20 Mar 2020 Closed: 16 Nov 2022 Parliament page
The Coronavirus covid-19 outbreak is the latest in a series of disease outbreaks that have spread internationally, presenting major challenges to communities, national governments and international institutions. Scientific knowledge and advice are foundational to the prevention, management and treatment of these global outbreaks, at both an international and national level. … Read more
12 Recommendations
15 Conclusions
1 Report
27 Oral sessions
71 Letters
29 Events
Activity timeline 129 events
23 Jun
2022
Correspondence
26 May
2022
Correspondence
20 May
2022
Correspondence
27 Apr
2022
Correspondence
30 Mar
2022
Oral evidence
30 Mar
2022
Formal meeting (oral evidence session) · Room 8, Palace of Westminster
2 Mar
2022
Oral evidence
2 Mar
2022
Formal meeting (oral evidence session) · Room 6, Palace of Westminster
17 Dec
2021
Correspondence
14 Dec
2021
Oral evidence
14 Dec
2021
Formal meeting (oral evidence session) · Room 8, Palace of Westminster
26 Oct
2021
Oral evidence
Oral evidence sessions 27 sessions
30 Mar 2022
View on parliament.uk
Professor Ann John · Scientific Pandemic Insights Group on Behaviours (SPI-B). Sir Patrick Vallance, Government Chief Scientific Adviser · UK Government
2 Mar 2022
View on parliament.uk
Dr Camilla Holten-Møller · Statens Serum Institut, Denmark Dr Raghib Ali · MRC Epidemiology Unit, the University of Cambridge Dr Sarah Scobie · Nuffield Trust Ed Humpherson · UK Statistics Authority Professor Graham Medley · Scientific Pandemic Influenza Group on Modelling (SPI-M).
14 Dec 2021
View on parliament.uk
Dame Kate Bingham · UK Vaccine Taskforce Dr Angelique Coetzee · South African Medical Association Dr Paul Burton · Moderna Dr Susan Hopkins · UK Health Security Agency Professor Steven Riley · UK Health Security Agency Professor Wei Shen Lim · JCVI COVID-19 sub-committee
26 Oct 2021
View on parliament.uk
Dr Sharon Alroy-Preis · Public Health Services, Israel Dr Thomas Waite · Department for Health and Social Care Professor Andrew Curran · Health and Safety Executive Professor Lucy Chappell · Department of Health and Social Care Professor Mario Mondelli · University of Pavia Professor Sir Andrew Pollard · Joint Committee on Vaccination and Immunisation Professor Sir Stephen Holgate · University of Southampton
16 Jun 2021
View on parliament.uk
Dr Susan Hopkins · UK Health Security Agency Professor Sir Andrew Pollard · Joint Committee on Vaccination and Immunisation Professor Wendy Barclay · Imperial College London
28 Apr 2021
View on parliament.uk
Dr Mary Ramsay · UK Health Security Agency (UKHSA) Dr Ruth Payne · University of Sheffield Professor Anthony Harnden · Joint Committee on Vaccination and Immunisation Professor Christopher Dye · University of Oxford Professor John Aston · University of Cambridge Professor Ran Balicer · Clalit Research Institute Professor Sir Munir Pirmohamed · Commission on Human Medicines
9 Mar 2021
View on parliament.uk
Professor Chris Whitty, Chief Medical Officer for England · Department of Health and Social Care Sir Patrick Vallance, Government Chief Scientific Adviser · UK Government
24 Feb 2021
View on parliament.uk
Dr Philip Dormitzer · Pfizer Madelaine McTernan · Department for Business, Energy and Industrial Strategy Nadhim Zahawi · Department for Health and Social Care Professor Anthony Harnden · Joint Committee on Vaccination and Immunisation Professor Sarah Gilbert · University of Oxford Professor Wendy Barclay · Imperial College London
17 Feb 2021
View on parliament.uk
Dr James Rubin · Kings College London Dr Johanna Hutchinson · Joint Biosecurity Centre James Hetherington · Joint Biosecurity Centre Professor Dame Angela McLean · HM Government Professor Mark Woolhouse OBE · University of Edinburgh Professor Sir John Bell · Oxford University
3 Feb 2021
View on parliament.uk
Formal Meeting
Mark Hewlett · NHS Test and Trace Steve McManus · NHS Test and Trace The Baroness Harding of Winscombe · National Institute for Health Protection
27 Jan 2021
View on parliament.uk
Dr Richard Harling MBE · Staffordshire County Council Greg Fell · Association of Directors of Public Health
13 Jan 2021
View on parliament.uk
Antonia Williams · HM Treasury Dr Mary Ramsay · UK Health Security Agency (UKHSA) Nadhim Zahawi · Department for Health and Social Care Professor Wei Shen Lim · JCVI COVID-19 sub-committee Sir Mene Pangalos · AstraZeneca Tom Keith-Roach · AstraZeneca UK
3 Nov 2020
View on parliament.uk
Professor Chris Whitty, Chief Medical Officer for England · Department of Health and Social Care Sir Patrick Vallance, Government Chief Scientific Adviser · UK Government The Lord Patel KT · House of Lords
17 Sep 2020
View on parliament.uk
Oral Evidence
Dr Susan Hopkins · UK Health Security Agency Dr Thomas Waite · Department for Health and Social Care Professor Carl Heneghan · University of Oxford Professor Sylvia Richardson · Cambridge Institute of Public Health, University of Cambridge Simon Thompson · Royal Mail The Baroness Harding of Winscombe · National Institute for Health Protection The Lord Bethell · Department for Health and Social Care
21 Jul 2020
View on parliament.uk
Oral Evidence
Rt Hon Matt Hancock · Department for Health and Social Care Sir Chris Wormald · Department of Health and Social Care
16 Jul 2020
View on parliament.uk
Oral Evidence
Sir Patrick Vallance, Government Chief Scientific Adviser · UK Government
1 Jul 2020
View on parliament.uk
Oral Evidence
Dr Jonathan Sheffield · National Institute for Health Research Kate Bingham · UK Vaccine Taskforce Professor Jonathan Van-Tam · Department for Health and Social Care Professor Sarah Gilbert · University of Oxford Professor Sir John Bell · Oxford University
10 Jun 2020
View on parliament.uk
Oral Evidence
Dr Nicholas Davies · London School of Hygiene and Tropical Medicine Professor Johan Giesecke · Karolinska Institute Professor Mark Woolhouse OBE · University of Edinburgh Professor Matt Keeling · University of Warwick Professor Neil Ferguson · Imperial College London
5 Jun 2020
View on parliament.uk
Oral Evidence
Phillip Duffy · HM Treasury Professor Carol Propper · Imperial College London Professor James Poterba · Massachusetts Institute of Technology Professor John Kay · St John's College, University of Oxford Professor John Loughhead · Department for Business, Energy and Industrial Strategy
22 May 2020
View on parliament.uk
Oral Evidence Session; Oral Evidence
Professor Andrew Curran · Health and Safety Executive Professor Catherine Noakes · University of Leeds Professor John Newton · Public Health England Professor Yvonne Doyle · Public Health England
13 May 2020
View on parliament.uk
Oral Evidence Session
Osama Rahman · Department for Education Professor Alan Penn · Ministry of Housing, Communities and Local Government Professor John Aston · University of Cambridge Professor Phil Blythe · Department for Transport
7 May 2020
View on parliament.uk
Oral Evidence Session; Oral Evidence
Professor David Peters · John Hopkins University Professor John Edmunds OBE · London School of Hygiene and Tropical Medicine Professor Sir David Spiegelhalter · University of Cambridge Professor Sir Ian Diamond, National Statistician · Office for National Statistics
28 Apr 2020
View on parliament.uk
Oral Evidence Session; Oral Evidence
Matthew Gould CMG MBE · NHSX Professor Christophe Fraser · University of Oxford Professor Danny Altmann · Imperial College London Professor Lilian Edwards · Newcastle Law School Professor Susan Michie · University College London
24 Apr 2020
View on parliament.uk
Oral Evidence
Dr Frank Atherton, Chief Medical Officer for Wales Dr Gregor Smith, Interim Chief Medical Officer for Scotland Dr Michael McBride, Chief Medical Officer for Northern Ireland Pete Wishart MP · Scottish Affairs Select Committee Professor Chris Whitty, Chief Medical Officer for England · Department of Health and Social Care
16 Apr 2020
View on parliament.uk
Dr James Rubin · Kings College London Professor Dr. Clemens Fuest · German Institute for Economic Research Professor Dr. Herwig Ostermann · Austrian Public Health Institute Professor Graham Medley · Scientific Pandemic Influenza Group on Modelling (SPI-M). Professor Xihong Lin · Harvard T.H. Chan School of Public Health
8 Apr 2020
View on parliament.uk
Formal Virtual Meeting
Dr Seon Kui Lee · Korea Centers for Disease Control and Prevention (KCDC) Kathy Hall · Department of Health and Social Care Professor Gabriel Leung · Li Ka Shing Faculty of Medicine, University of Hong Kong Professor John Newton, Government adviser on increasing Covid-19 testing capacity · HM Government Professor Stephen Powis · NHS England Sir Paul Nurse · The Francis Crick Institute Steve Bates · Office for Life Sciences
25 Mar 2020
View on parliament.uk
Oral Evidence
Title HC No. Published Items Response
First Report - The UK response to covid-19: use of scientific ad… HC 136 8 Jan 2021 27 Responded
Recommendations & Conclusions
27 results
1 Recommendation
First Report - The UK response to …
The coronavirus pandemic marks the most significant test of the UK’s emergency advisory and decision-making...
The coronavirus pandemic marks the most significant test of the UK’s emergency advisory and decision-making structures in living memory. As such, it is important that lessons are drawn throughout and applied so that the Government and future Governments may be … Read more
Department for Science, Innovation and Technology
View details
2 Conclusion
First Report - The UK response to …
The Cabinet Office and Government Office for Science should update SAGE guidance to set out...
The Cabinet Office and Government Office for Science should update SAGE guidance to set out the role that SAGE will play in advising the Government’s long-term management of emergency scenarios. (Paragraph 34) Activation and operation of SAGE
Government Response
The responsibility for long-term management of emergencies (including prevention, contingency planning, response and recovery) sits with the accountable, policy- owning Government Departments and their respective Ministers in accordance with the … Read more
Department for Science, Innovation and Technology
View details
3 Conclusion
First Report - The UK response to …
We are satisfied that the SAGE mechanism responded to the advent of the novel coronavirus...
We are satisfied that the SAGE mechanism responded to the advent of the novel coronavirus in a timely manner and that the most up-to-date scientific research and understanding was readily available to inform the Government from the outset. Nevertheless, we … Read more
Government Response
No other papers were commissioned or tabled at those meetings. Minutes for the first two SAGE meetings about the response to Coronavirus (Covid 19), held on 22 and 28 January … Read more
Department for Science, Innovation and Technology
View details
4 Conclusion
First Report - The UK response to …
It is disappointing that the details of SAGE’s preliminary meetings were not made public for...
It is disappointing that the details of SAGE’s preliminary meetings were not made public for over two months, leading to unnecessary concern and confusion over what advice the Government had been receiving. Indeed, were it not for our early enquiries, … Read more
Government Response
Through SAGE and its sub-committees, the Government has drawn on advice from a wide and diverse pool of advisers from across the scientific community. This has included securing input from; … Read more
Department for Science, Innovation and Technology
View details
5 Recommendation
First Report - The UK response to …
We believe the initial response in setting up SAGE was timely.
We believe the initial response in setting up SAGE was timely. We have heard from some sectors of the science community that the community was not consulted appropriately. The Government should set out in response to this Report how in … Read more
Department for Science, Innovation and Technology
View details
6 Recommendation
First Report - The UK response to …
SAGE has been activated for the longest continual period since its inception, which brings to...
SAGE has been activated for the longest continual period since its inception, which brings to question how sustainably the group can maintain its current level of high activity. We acknowledge senior scientists’ comments of frequent working round the clock, and … Read more
Department for Science, Innovation and Technology
View details
7 Conclusion
First Report - The UK response to …
Whilst we welcome the eventual disclosure of SAGE participants, the fact that the delay was...
Whilst we welcome the eventual disclosure of SAGE participants, the fact that the delay was attributed to advice from the Centre for the Protection of National Infrastructure (CPNI) gives us cause for concern. As suggested by Professor Chris Whitty, the … Read more
Government Response
SAGE minutes published online already contain details of the Senior Civil Servants as well as special advisers present at meetings. Names of more junior observer government officials who attend the … Read more
Department for Science, Innovation and Technology
View details
8 Recommendation
First Report - The UK response to …
Regarding the disclosure of Government officials observing SAGE meetings, we agree with the redaction of...
Regarding the disclosure of Government officials observing SAGE meetings, we agree with the redaction of information to protect the personal data of individuals including junior officials at the time of the emergency. In the interests of transparency, and to have … Read more
Department for Science, Innovation and Technology
View details
9 Conclusion
First Report - The UK response to …
It is regrettable that full transparency was not achieved in time for the JBC’s inauguration...
It is regrettable that full transparency was not achieved in time for the JBC’s inauguration on 1 June. We welcome the disclosure of the expert advisory boards supporting the JBC. Nevertheless, the Department of Health and Social Care (DHSC) has … Read more
Government Response
GO-Science has released 684 papers (as at 30.04.2021) and the minutes from COVID-SAGE which forms the advice provided to Ministers. The current aim is to release papers about two weeks … Read more
Department for Science, Innovation and Technology
View details
10 Recommendation
First Report - The UK response to …
Given the frequent reporting of the views of SAGE advisers in the media— particularly where...
Given the frequent reporting of the views of SAGE advisers in the media— particularly where these have diverged from decisions taken by the Government— and the continued public interest in the evidence base underlying decisions made, we are satisfied for … Read more
Department for Science, Innovation and Technology
View details
11 Conclusion
First Report - The UK response to …
Transparency in the evidence behind Government decisions enables higher quality decision-making through scrutiny, and better...
Transparency in the evidence behind Government decisions enables higher quality decision-making through scrutiny, and better understanding of the reasons for those decisions. While calls for the publication of SAGE evidence from this Committee and many others were eventually heeded, it … Read more
Government Response
The Government is keen to better understand the wider health impacts9 of the Covid- 19 pandemic as identified by the Chief Medical Officer. These health impacts may relate to mortality, … Read more
Department for Science, Innovation and Technology
View details
12 Recommendation
First Report - The UK response to …
It has been made clear to us that policy decisions throughout the coronavirus pandemic have...
It has been made clear to us that policy decisions throughout the coronavirus pandemic have not been based solely on medical and epidemiological science, but rather have been developed with a wide range of inputs that include scientific research and … Read more
Department for Science, Innovation and Technology
View details
13 Recommendation
First Report - The UK response to …
The public has shown a strong appetite for more information.
The public has shown a strong appetite for more information. The Government should attempt to quantify the four forms of health impacts identified by Professor Whitty. Further, it should consider whether it is possible to provide an analysis of—either consistently … Read more
Department for Science, Innovation and Technology
View details
14 Conclusion
First Report - The UK response to …
As indicated by the Chief Medical Officer for England, the SAGE secretariat faced “huge pressure”...
As indicated by the Chief Medical Officer for England, the SAGE secretariat faced “huge pressure” in managing the monumental task of organising SAGE whilst adhering to the principles of transparent and scrutable scientific advice. We commend the efforts of officials … Read more
Government Response
The Government considers the understanding and mitigation of negative indirect impacts to be imperative to the recovery from Covid-19 and this is part of the C O’s remit. The CO … Read more
Department for Science, Innovation and Technology
View details
15 Conclusion
First Report - The UK response to …
We applaud the dedication with which the scientific community within the UK and globally have...
We applaud the dedication with which the scientific community within the UK and globally have directly engaged with the public, in addition to their intensive studies of the coronavirus itself. We are also grateful to those within universities and research … Read more
Government Response
DHSC recognises that cross-organisational working is more important than ever given the nature and impact of the Covid-19 pandemic. As a result, various channels of data access and sharing have … Read more
Department for Science, Innovation and Technology
View details
16 Recommendation
First Report - The UK response to …
We believe that a gap persists in the transparency of the advice that is given...
We believe that a gap persists in the transparency of the advice that is given to the Government, outside of the auspices of SAGE, particularly on the topic of non- medical impacts of the pandemic and related Government interventions. While … Read more
Department for Science, Innovation and Technology
View details
17 Recommendation
First Report - The UK response to …
Given the UK’s strengths in statistical analysis and data science, it is regrettable that poor...
Given the UK’s strengths in statistical analysis and data science, it is regrettable that poor data flows, delays in data-sharing agreements and a general lack of structuring and data integration across both the health and social care sectors have throttled … Read more
Department for Science, Innovation and Technology
View details
18 Conclusion
First Report - The UK response to …
We are satisfied that the science advice informing the Government has drawn upon some of...
We are satisfied that the science advice informing the Government has drawn upon some of the best expertise that the UK—and indeed the world—has to offer. We acknowledge the initial dominance of modelling expertise on SAGE and believe this is … Read more
Government Response
The Government keeps all non–pharmaceutical interventions and social distancing rules under constant review to ensure the measures remain necessary and proportionate. For example, the Government is legally required to review … Read more
Department for Science, Innovation and Technology
View details
19 Conclusion
First Report - The UK response to …
The Government was too slow to increase testing capacity to the levels required to help...
The Government was too slow to increase testing capacity to the levels required to help contain the spread of the coronavirus. We have previously suggested that strategy was driven by the capacity available, rather than strategy driving the necessary increase … Read more
Government Response
The Government does not believe that its approach to test, trace and isolate should come down to a simple either/or between a national or local approach, but rather that a … Read more
Department for Science, Innovation and Technology
View details
20 Conclusion
First Report - The UK response to …
The Government was slow to move once it realised that coronavirus testing required a rapid...
The Government was slow to move once it realised that coronavirus testing required a rapid expansion and did not engage sufficiently with the wide array of scientific expertise available within the UK—particularly within our universities and research institutes. While we … Read more
Government Response
The Government does not believe that its approach to test, trace and isolate should come down to a simple either/or between a national or local approach, but rather that a … Read more
Department for Science, Innovation and Technology
View details
21 Conclusion
First Report - The UK response to …
The Committee will report separately and more fully on the test, trace and isolate system...
The Committee will report separately and more fully on the test, trace and isolate system and the mass testing programme in due course. But in considering the role of science advice, and its influence on Government decisions, we are concerned … Read more
Government Response
The Government does not believe that its approach to test, trace and isolate should come down to a simple either/or between a national or local approach, but rather that a … Read more
Department for Science, Innovation and Technology
View details
22 Conclusion
First Report - The UK response to …
The creation of NHS Test and Trace involves a budget of £22 billion for financial...
The creation of NHS Test and Trace involves a budget of £22 billion for financial year 2020–21 and the justification for most of its spending being on the central part of the system, rather than through local public health teams, … Read more
Government Response
The Government does not believe that its approach to test, trace and isolate should come down to a simple either/or between a national or local approach, but rather that a … Read more
Department for Science, Innovation and Technology
View details
23 Recommendation
First Report - The UK response to …
The Government should: explain clearly the justification for taking a relatively centralised approach to test,...
The Government should: explain clearly the justification for taking a relatively centralised approach to test, trace and isolate; set out its assessment of the impact of the system on the spread of the virus since the outset, including on health … Read more
Department for Science, Innovation and Technology
View details
24 Recommendation
First Report - The UK response to …
Throughout the pandemic, the UK has relied on its own bespoke system of science advice...
Throughout the pandemic, the UK has relied on its own bespoke system of science advice and guidance on non-pharmaceutical interventions, while at the same time global-level guidance has been issued regularly by the World Health Organisation (WHO). There have also … Read more
Department for Science, Innovation and Technology
View details
25 Recommendation
First Report - The UK response to …
Given the importance of refining interventions to mitigate both impacts on public health and economic...
Given the importance of refining interventions to mitigate both impacts on public health and economic recovery, a review of social distancing measures came quite late. While the scientific approach quite rightly waits for the evidence before making a definitive recommendation, … Read more
Department for Science, Innovation and Technology
View details
26 Conclusion
First Report - The UK response to …
The development of vaccines and therapeutics is a policy area in which it is right...
The development of vaccines and therapeutics is a policy area in which it is right that science must lead the way, so that there may be a high level of confidence that a rigorous approach has been taken towards safety … Read more
Department for Science, Innovation and Technology
View details
27 Conclusion
First Report - The UK response to …
We acknowledge that a large part of the success to date into the development of...
We acknowledge that a large part of the success to date into the development of covid-19 vaccines and therapeutics can be credited to lessons learned from previous outbreaks and efforts made to prepare for future crises. As further promising vaccine … Read more
Department for Science, Innovation and Technology
View details
Correspondence 71 letters
23 Jun 2022 Correspondence from Rt Hon Sajid Javid MP, Secretary of State for Health and Social Care, relating to the rapid stand-up of Covid-19 testing
Parliament page
26 May 2022 Correspondence from the Chair to Rt Hon Sajid Javid MP, Secretary of State for Health and Social Care, relating to the rapid stand-up of Covid-19 testing
Parliament page
20 May 2022 Correspondence from Rt Hon Sajid Javid MP, Secretary of State for Health and Social Care, to the Chair relating to the rapid stand-up of Covid-19 testing
Parliament page
27 Apr 2022 Correspondence from the Chair to Rt Hon Sajid Javid, Secretary of State for Health and Social Care, regarding Covid-19 Testing
Parliament page
17 Dec 2021 Correspondence from Rt Hon Sajid Javid MP, Secretary of State for Health and Social Care, regarding the rollout of treatments for COVID-19 this winter
Parliament page
21 May 2021 Correspondence from Dr Mary Ramsay, Head of Immunisation, Public Health England, to the Chair relating to follow up evidence on COVID-19 vaccines
Parliament page
12 May 2021 Correspondence from Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care, to the Chair regarding the Government response to the Committee’s COVID-19 Report
Parliament page
16 Mar 2021 Correspondence from Baroness Harding to Chair regarding contact tracing in Scotland
Parliament page
2 Mar 2021 Correspondence from Jeane Freeman MSP, Cabinet Secretary for Health and Sport, Scottish Government to Baroness Harding relating to evidence to the Committee
Parliament page
12 Feb 2021 Correspondence from Baroness Harding to the Chair relating to the impact of Test and Trace on 'R'
Parliament page
12 Feb 2021 Correspondence from Professor Wei Shen Lim to the Chair relating to follow up evidence on vaccinations
Parliament page
5 Feb 2021 Correspondence from the Chair to Baroness Harding regarding follow up evidence
Parliament page
3 Feb 2021 Correspondence from the Chair to Rt Hon Matt Hancock, Secretary of State for Health and Social Care, regarding follow up evidence
Parliament page
20 Jan 2021 Correspondence from Nadhim Zahawi MP, Minister for COVID-19 Vaccine Deployment, relating to follow up evidence
Parliament page
13 Jan 2021 Correspondence from Dr Clive Dix, Interim Chair UK Vaccine Taskforce, to the Chair relating to COVID Vaccine Effectiveness
Parliament page
23 Dec 2020 Correspondence from the Chair to Dr Clive Dix, Interim Chair UK Vaccine Taskforce, 23 December 2020
Parliament page
10 Dec 2020 Correspondence from the Prime Minister to the Chairs of the Science & Technology Committee and HCLG Committee re Covid-19 contact tracking and tracing
Parliament page
11 Nov 2020 Correspondence from Professor Chris Whitty, Chief Medical Officer for England, to the Chair regarding follow up evidence
Parliament page
4 Nov 2020 Correspondence from the Chair to Rt Hon Alok Sharma MP relating to the Vaccine Manufacturing Sites
Parliament page
4 Nov 2020 Correspondence from the Rt Hon Alok Sharma MP to the Chair regarding the Vaccine Manufacturing Sites
Parliament page
4 Nov 2020 Correspondence from Professor Chris Whitty to the chair, re clarification of oral evidence on 3 November 2020
Parliament page
27 Oct 2020 Correspondence from Baroness Dido Harding to the Chair regarding the technical issue around case uploads
Parliament page
20 Oct 2020 Correspondence from Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care, regarding child care support bubble, self isolation and the 10pm curfew
Parliament page
16 Oct 2020 Correspondence from Sir Patrick Vallance, Government Chief Scientific Adviser, regarding the science advice behind COVID-19 measures
Parliament page
16 Oct 2020 Correspondence from Baroness Dido Harding regarding follow up evidence
Parliament page
16 Oct 2020 Correspondence from Baroness Dido Harding regarding Case Uploads
Parliament page
8 Oct 2020 Correspondence from the Chair to Lord Bethell regarding follow up evidence
Parliament page
8 Oct 2020 Correspondence from the Chair to Baroness Dido Harding regarding follow up evidence
Parliament page
30 Sep 2020 Correspondence from the Chair to Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care, regarding science advice behind COVID-19 measures
Parliament page
30 Sep 2020 Correspondence from the Chair to Sir Patrick Vallance, Government Chief Scientific Adviser, regarding science advice behind COVID-19 measures
Parliament page
29 Sep 2020 Correspondence from the Chair to Baroness Dido Harding regarding follow up evidence
Parliament page
29 Sep 2020 Correspondence from the Chair to Lord Bethell regarding follow up evidence
Parliament page
29 Sep 2020 Correspondence from Rt Hon Alok Sharma MP regarding acquisition of the Benchmark Vaccines Limited Site in Braintree
Parliament page
29 Sep 2020 Correspondence from the Chair to Rt Hon Alok Sharma MP relating to the Vaccines Taskforce
Parliament page
16 Sep 2020 Correspondence from Professor Chris Whitty relating to the testing of healthcare and social care workers in surveillance studies
Parliament page
11 Sep 2020 Correspondence from Rt Hon Alok Sharma MP, Secretary of State, Department for Business, Energy and Industrial Strategy relating to Vaccines Taskforce
Parliament page
22 Jul 2020 Correspondence from the Prime Minister regarding social distancing
Parliament page
16 Jul 2020 Correspondence from Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care, regarding testing health and care workers
Parliament page
14 Jul 2020 Professor Chris Whitty to the chair, re COVID-19 antigen testing of asymptomatic cases in the health and care sectors
Parliament page
10 Jul 2020 Correspondence from Rt Hon Alok Sharma MP, Secretary of State for Business, Energy and Industrial Strategy, relating to the sustainability of university research and COVID-19
Parliament page
2 Jul 2020 Correspondence from Greg Clark MP, Chair, to Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care, relating to COVID-19 antigen testing of asymptomatic cases in the health and care sectors
Parliament page
2 Jul 2020 Correspondence from Greg Clark MP, Chair, to Professor Chris Whitty, Chief Medical Officer for England, relating to COVID-19 antigen testing of asymptomatic cases in the health and care sectors
Parliament page
25 Jun 2020 Correspondence from Lord Bethell, Minister for Innovation, Department for Health and Social Care, to the Chair, regarding test and trace
Parliament page
19 Jun 2020 Correspondence from the Chair to Lord Bethell, Minister for Innovation, Department for Health and Social Care, regarding test and trace
Parliament page
9 Jun 2020 Correspondence from the Chairs of the S&T and HCLG Committees to the Prime Minister, regarding Enforcement of Contact Tracking and Tracing
Parliament page
29 May 2020 Correspondence from Sir Patrick Vallance, Chief Scientific Adviser, to Chair regarding social distancing evidence
Parliament page
29 May 2020 Correspondence from the Chair to the Prime Minister regarding social distancing evidence
Parliament page
22 May 2020 Correspondence from Professor Sir Ian Diamond, National Statistician, UK Statistics Authority, relating to further information and clarifications from oral evidence session
Parliament page
22 May 2020 Correspondence from Rt Hon Alok Sharma MP, Secretary of State, Department for Business, Energy and Industrial Strategy, relating to
Parliament page
22 May 2020 Correspondence from the Chair to Sir Patrick Vallance, relating social distancing evidence
Parliament page
22 May 2020 Correspondence from Osama Rahman, Chief Scientific Adviser, Department for Education
Parliament page
19 May 2020 Correspondence from Chair to the Prime Minister regarding lessons learned so far from the COVID-19 pandemic
Parliament page
15 May 2020 Correspondence from Osama Rahman, Chief Scientific Adviser, Department for Education, to Chair, regarding follow-up evidence
Parliament page
15 May 2020 Correspondence from the Chair to Osama Rahman, Chief Scientific Adviser, Department for Education, replying to follow-up evidence
Parliament page
7 May 2020 Correspondence from the Rt Hon Simon Hart MP, Secretary of State for Wales, to the Chair relating to COVID-19 Testing Portal for Keyworkers
Parliament page
7 May 2020 Correspondence from Kathy Hall, Director of COVID-19 Testing Strategy, Department of Health and Social Care, to the Chair relating to the prioritisation of testing for essential workers
Parliament page
7 May 2020 Correspondence from Duncan Selbie, Chief Executive, Public Health England, to the Chair relating to Evidence behind COVID-19 Testing Strategy
Parliament page
7 May 2020 Correspondence from Matthew Gould, Chief Executive for NHSX, to the Chair relating to follow-up from the Committee Session on 28 April 2020
Parliament page
1 May 2020 Correspondence from Sharon Peacock CBE, Public Health England, to the Chair regarding Evidence Behind COVID-19 Testing Strategy
Parliament page
1 May 2020 Correspondence from the Chair to Sharon Peacock CBE, Public Health England, regarding Evidence Behind COVID-19 Testing Strategy
Parliament page
27 Apr 2020 Correspondence from Professor Chris Whitty, Chief Medical Officer, and Sir Patrick Vallance, Chief Scientific Adviser, relating to SAGE Publications
Parliament page
27 Apr 2020 Correspondence from the Chair to Professor Chris Whitty, Chief Medical Officer, and Sir Patrick Vallance, Chief Scientific Adviser, relating to SAGE Publications
Parliament page
17 Apr 2020 Correspondence from the Chair to Professor John Newton, Government Adviser, relating to increasing Covid-19 testing capacity
Parliament page
17 Apr 2020 Correspondence from the Chair to Stephen Powis, National Medical Director for NHS England, relating to COVID-19 testing
Parliament page
17 Apr 2020 Correspondence from Rt Hon Matt Hancock, Secretary of State for Health and Social Care, to Greg Clark MP, Chair, relating to COVID-19 Vaccine Manufacturing
Parliament page
17 Apr 2020 Correspondence from the Chair to Kathy Hall, Director of Covid-19 testing strategy, relating to COVID-19 testing capacity
Parliament page
9 Apr 2020 To committee Letter from Patrick Vallance to Greg Clark on SAGE composition
Parliament page
3 Apr 2020 Correspondence from the Chair to Professor Chris Whitty, Chief Medical Officer, relating to SAGE Membership
Parliament page
3 Apr 2020 Correspondence from the Chair to Professor Sharon Peacock, Public Health England, relating to COVID-19 Testing
Parliament page
3 Apr 2020 Correspondence from the Chair to Rt Hon Matt Hancock, Secretary of State for Health and Social Care, relating to COVID-19 Vaccines
Parliament page
3 Apr 2020 Correspondence from the Chair to Sir Patrick Vallance, Chief Scientific Adviser, relating to SAGE Membership
Parliament page